nebulized glutathione for copd A review of drug delivery in Antioxidants and Chronic Obstructive Pulmonary
Description
Protein Eng 1998
Rietsch & Beckwith, 1998)
This mechanism may be particularly relevant for patients who had significant insulin resistance before starting GLP-1 therapy
M., Mena, R., Guil-Luna, S., Conde, F., Hernndez, V., Toledano, M., Gudio, V., Raponi, M., Billard, C., Villar, C., Daz, C., Gmez-Barbadillo, J., De la Haba-Rodrguez, J., Myant, K., Aranda, E., and Rodrguez-Ariza, A
